Samsung Bioepis Launches First Product In Japan Under NIPRO Partnership
Tokyo: Samsung Bioepis Co Ltd has launched Ustekinumab BS 45 mg Syringe for S.C. Injection? NIPRO?, a biosimilar referencing Stelara (ustekinumab), marking its first product launch in Japan with NIPRO Corporation (NIPRO).
According to BERNAMA News A…